Ann: Exceptional VitroGro Clinical Results Contin, page-6

re: Ann: Exceptional VitroGro Clinical Result... It was a good announcement in the way that we know things are humming along smoothly, potential partners would be impressed and probably more excited then what the market is showing, that will change imo. $4bn market to share in:

Get only 10% of that market (just to low ball) = $400m revenue

Say we do a deal/partner and get only 30% of this ($400m) returned as profit = $120m

That's approx 87c EPS, would we fetch a 10XPE ?? ($8.70??)

Ah you can dream, that's free... don't forget our Commercialisation Strategy

Tissue Therapies:
Is already using the exceptional clinical trial data in formal negotiations with identified potential healthcare partners.
Has successfully completed commercial scale GMP manufacturing.
Is proceeding with the final clinical trial necessary for approval for sale in most territorities outside the United States.
Is proceeding with development of other commercial applications for VitroGro and other technologies for the treatment of psoriasis, scar prevention and treatment and potential treatments for various cancers including those of the breast, colon and prostate.